Trial NCT02244112

View at ClinicalTrials.gov 
Org. Study IDs: OPZ009

Last trial update was posted on 2021-02-21

MeSH Interventions

Midazolam

MeSH Conditions

Neoplasms

Other Conditions

Advanced Non-Central Nervous System (CNS) Malignancies

Stopping Reasons

Why study stopped revised to "A program evaluation identified that the safety profile and pharmacokinetic (PK) characteristics of the formulation used in all oprozomib studies required further optimization and thus enrollment in OPZ009 was halted

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID